Conference Calendar

February 16-20 - AAAS Annual Meeting 2017

February 16-18 - International College of Oral Implantologists Symposium

Complete Calendar »

Earnings Calendar

Feb 24 @ 3:30 PM ET - Wright Medical

Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Dental News Roundup June 2014 BY MATTHEW JAFFE, JUNE 26, 2014

Align Technology reported financial results for 1Q:14. Net revenue was $180.6 million, beating consensus estimates by 2% and increasing 18% from $153.6 in 1Q:13. Gross margin increased to 76.0% in 1Q:14 from 73.5% in 1Q:13. Clear aligner net revenues grew 19% to $168.2 million and scanner and CAD/CAM net revenue grew 3% to $12.4 million when compared to the same quarter last year. By product, revenue grew at: Invisalign Full 22%, Invisalign Express 22%, Non-case (18%) respectively in 1Q:14. All growth rates are on a reported basis.

Nobel Biocare reported financial results for 1Q:14. Revenue was €138.8 million ($192.2 million), missing consensus estimates by 2%, and representing increase of 3% from €141.5 million ($181.35 million) in 1Q:13. Gross margin declined slightly to 75.1% in 1Q:14 from 76.6% in 1Q:13. The company's Europe, Middle East and Africa (EMEA), Americas and Asia/Pacific regions grew at 2%, 3%, and 6% respectively in 1Q:14. All growth rates are on a constant currency basis.

Patterson Companies reported financial results for 4Q:14. Net sales were $1,102.1 million in 4Q:14, missing consensus estimates by 2%, and representing an increase of 14% compared to $964.9 million in 4Q:13. Gross margin declined to 28.7% in 4Q:14 from 33.6% in 4Q:13. Dental sales, which are about 60% of Company sales, decreased 1.5%, compared to the fourth quarter last year to $622.8 million in the fourth quarter this year. The company's results by category for Consumable Dental Supplies, Dental Equipment and Software and Other Dental Services and Products were 0.4%, (4.7%) and 0% respectively. All growth rates are on a constant currency basis.

Sirona reported financial results for its 2Q:14. Revenue was $282.7 million, beating consensus estimates by 3% and increasing 3% from $267.3 million in 2Q:13. Gross margin decreased in 2Q:14 to 53.6% from 54.1% in 2Q:13. The company's segments grew at: Instruments 9%, CAD/CAM 3%, Imaging Systems 3%, and Treatment Centers 1% in 2Q:14. Domestic revenue grew 4.5%, while international revenue grew 2.3% compared to the same quarter last year. All growth rates are on a constant currency basis.

Straumann reported financial results. Revenue in 1Q:14 was CHF 179.8 million ($202.7 million), beating consensus by 2% and representing an increase of 6% from CHF 174.8 million ($184.0 million) in 1Q:13. The company's Europe, North America, Asia/Pacific and Rest of the World regions grew at 4%, 5%, 8% and 29% respectively in 1Q:14. All growth rates are on a constant currency basis.

Henry Schein reported financial results for 1Q:14. Net sales were $2,430 million in 1Q:14, in line with consensus estimates and representing an increase of 6% compared to $2,294 million in 1Q:13. Gross margin slightly increased to 28.7% in 1Q:14 from 28.2% in 1Q:13. The company's segments grew at: Dental 4%, Animal Health 2%, Medical 2%, Technology and Value-added Service 6% in 1Q:14. All growth rates are on a constant currency basis and exclude affects of acquisitions.

Henry Schein acquired 50% of Dental Speed Graph, the largest dental consumable merchandise direct marketer in Brazil, 170 employees, and 2013 sales of appropriately $28 million. The acquisition target has a robust e-commerce platform, operates in 27 countries and with this acquistion, Henry Schein enters the South American marketplace. The founder Luciano Chaves will retain 50% of the company.

Henry Schein will acquire assets of Sirona Direct, the distribution business in Paris and Normany for Sirona Dental Systems. Additionally, Henry Schein has entered an exclusive distribution agreement with Sirona for their full line of products covering most of France. These acquisitions and agreements make Henry Schein Sirona's exclusive distributor across most of France.

Align Technology provided an update on the International Trade Commission (ITC) cease and desist order against ClearCorrect. In March of 2012, Align filed a complaint with the ITC that ClearCorrect digital data and treatment plans imported from Pakistan infringed on Align's patents. On April 3, 2014, the ITC issued a cease and desist order to prohibit the ClearCorrect entities from importing, selling, advertising or distributing digital data treatment plans that infringed on the patents. ClearCorrect moved for a stay of the order, citing "potentially catastrophic consequences" which was temporarily granted on June 2, 2014 based on procedural grounds, while awaiting a decision from the Federal Circuit court.

Straumann entered a bilateral distribution agreement with botiss, a Berlin developer of biomaterials for dental bone and tissue regeneration. Straumann will be the exclusive distributor of botiss regenerative products in Central and Western Europe and the Americas, and they will co-distribute in Germany. botiss will receive rights to distribute Straumann's Emdogain product in Germany, Eastern Europe and the Middle East. Straumann also received put options, which if excised are worth up to 30% of botiss in 2017. The cross distribution plan will begin in October 2014.

Straumann and 3M announced a trusted connection with the Straumann Cares system for the 3M True Definition Scanner (TDF). This will allow dentist to restore a Straumann implant with Cares prosthetic from a single TDF intra-oral scan. In the new workflow, after the digital impression is captured, the dentist can now select a Straumann implant in the scanners prescription screen and send to a dental lab using the Cares system.

Henry Schein elected Dr. Dianne Rekow to its Board of Directors. Professor E. Dianne Rekow, D.D.S., PhD. is Dean of King's College London Dental Institute and Professor of Orthodontics. Prior to Kings College, Dr. Rekow was a Professor of Orthodontics at New York University for 10 years. She formerly served as president of the International Association for Dental Research and president of the American Association of Dental Research.

Patterson Companies announced the retirement of Executive Vice President & CFO R. Stephen Armstrong, who has been with the company for 15 years and will depart in October. Ann B. Gugino, who has been Patterson's vice president of strategy and planning since 2012, will succeed Mr. Armstrong as CFO effective November 1, 2014. Ms. Gugino also serves on the board of directors of Oral health America and Washburn Children's Center.

Email this to a colleague: